Melanoma, Secondary cancers, Skin cancer
Results
Phase 2
This trial looked at nilotinib for that had spread to the surrounding tissues, or to another part of the body.
It was for two rare types of melanoma:
acral melanoma
mucosal melanoma
The trial was supported by Cancer Research UK. It was open for people to join between 2009 and 2014. The team published the results in 2024.
Recruitment start: 15 December 2009
Recruitment end: 4 August 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor James Larkin
Cancer Research UK
Experiment Cancer Medical Centre (ECMC)
Institute of Cancer Research (ICR)
NIHR Clinical Research Network: Cancer
Novartis
The Royal Marsden NHS Foundation Trust
This is Cancer Research UK trial number CRUK/09/028.
Last reviewed: 25 September 2024
CRUK internal database number: 4274
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
